Current Concepts of the Pathogenesis of Aplastic Anemia

Curr Pharm Des. 2019;25(3):236-241. doi: 10.2174/1381612825666190313113601.

Abstract

Abnormal activation of the immune system plays an important role in the pathogenesis of aplastic anemia (AA). Various immune cells and cytokines constitute a complex immune network, leading to bone marrow failure. The known pathogenesis is an increase of the myeloid dendritic cell (mDC)/ plasmacytoid dendritic cell (pDC) ratio, which causes the ratio of T helper (Th)1/Th2 to be skewed in favor of Th1 and eventually leads to an abnormal activation of cytotoxic T lymphocyte (CTL). The antigens that stimulate T cells in the context of AA remain unknown. In this process, regulatory T (Treg), Th17, natural killer (NK) cell, memory T cell and negative hematopoietic regulatory factors are also involved. In addition, genetic background (e.g., chromosomal abnormalities, telomere attrition, somatic cell mutations), abnormal bone marrow hematopoietic microenvironment and viral infection may also contribute to the pathogenesis of AA. This review summarizes the recent studies of the pathogenesis of AA and the current status of AA research.

Keywords: Aplastic Anemia; bone marrow failure; cytokines; immunosuppressive therapies; myeloid dendritic cell; pathogenesis..

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Anemia, Aplastic / physiopathology*
  • Bone Marrow / pathology
  • Dendritic Cells / cytology*
  • Hematopoiesis
  • Humans
  • Killer Cells, Natural / cytology
  • T-Lymphocytes, Regulatory / cytology
  • Th1 Cells / cytology